UNITED STATES · SECURITIES AND EXCHANGE COMMISSION · WASHINGTON, D.C. 20549 · FORM 8-K · CURRENT REPORT · PURSUANT TO SECTION 13 OR 15(D) OF THE · SECURITIES EXCHANGE ACT OF 1934 · Date of Report (date of earliest event reported): June 9, 2021 · (Exact name of registrant as specified in its charter)
Item 7.01 Regulation FD Disclosure · AAR CORP.’s Vice President, Chief Financial Officer and Treasurer, Michael J. Sharp, presented at the Cowen and Company 37th Annual Aerospace/Defense & Transportation Conference on Thursday, February 4, 2016 in New York City. Attached as Exhibit 99.1 are the slides used by Mr. Sharp in his presentation. The information in this Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of t...
New York · 001-00035 · 14-0689340 ; (State or other jurisdiction of incorporation) · (Commission File Number) · (IRS Employer Identification No.)
Item 1.01 Entry into a Material Definitive Agreement · On September 21, 2016, Hyperdynamics Corporation (“Hyperdynamics,” the “Company,” “we” or “us”), through its wholly-owned subsidiary, SCS Corporation (“SCS”) received an implementing Presidential Decree from the Republic of Guinea authorizing a Second Amendment (the “Second Amendment”) to the Hydrocarbon Production Sharing Contract, dated September 22, 2006, between SCS and the Republic of Guinea, as amended on Marc...
Delaware, 1-34392, 22-3672377 ; (State or other jurisdiction, (Commission File, (IRS Employer ; of incorporation), Number), Identification No.)
Item 2.02. Results of Operations and Financial Condition. The registrant’s press release dated January 19, 2016, regarding its financial results for the periods ended December 31, 2015, including consolidated financial statements for the periods ended December 31, 2015, is Attachment I of this Form 8-K. Attachment II are the slides for IBM’s Chief Financial Officer Martin Schroeter’s fourth quarter earnings presentation on January 19, 2016, as well as certain reconciliation and other infor...
0001104659-18-045346.txt : 20180717 0001104659-18-045346.hdr.sgml : 20180717 20180716214954 ACCESSION NUMBER: 0001104659-18-045346 CONFORMED SUBMISSION TYPE: 425 PUBLIC DOCUMENT COUNT: 38...
0000950157-24-000203.txt : 20240213 0000950157-24-000203.hdr.sgml : 20240213 20240213172458 ACCESSION NUMBER: 0000950157-24-000203 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT...
SECURITIES AND EXCHANGE COMMISSION · Washington, D.C. 20549 · FORM 8-K · CURRENT REPORT · PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 · Date of Report (Date of Earliest Event Reported) – January 11, 2006 · WEST PHARMACEUTICAL SERVICES, INC. (Exact name of registrant as specified in its charter)
April 3, 2015 · Dear IBM Stockholder: By now you should have received our Annual Report for 2014 and Proxy Statement for our upcoming 2015 Annual Meeting of Stockholders. Our Annual Report begins with a letter from our Chairman, President and Chief Executive Officer, Ginni Rometty. This letter describes our 2014 performance — a year marked with bold moves and strategic investments, dynamic shifts in our portfolio, and transformation that supports IBM’s differentiation in the marketplace. T...